Hemostats Market Size, Share & Industry Analysis, By Product (Active Hemostats, Passive Hemostats, Combination Hemostats, and Others), By Application (Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery and Others), By End-User (Hospitals & ASCs, Tactical Combat Casualty Care Centers, and Others), and Regional Forecast, 2024-2032

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2023

Estimated Year

2024

Forecast Period

2024-2032

Historical Period

2019-2022

Growth Rate

CAGR of 7.9% from 2024-2032

Unit

Value (USD billion)

Segmentation

By Product

• Active Hemostats
  • Thrombin Based Hemostats
  • Fibrin Sealants
• Passive Hemostats
  • Plant-based Hemostats
  • Animal-based Hemostats
  • Others
• Combination Hemostats
• Others

By Application

• Trauma
• Cardiovascular Surgery
• General Surgery
• Plastic Surgery
• Orthopedic Surgery
• Neurosurgery
• Others

By End-User

• Hospitals & ASCs
• Tactical Combat Casualty Care Centers
• Others

By Region

• North America (By Product, Application, End-User, and Country)
  • U.S.
  • Canada
• Europe (By Product, Application, End-User, and Country/Sub-region)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Product, Application, End-User, and Country/Sub-region)
  • China
  • Japan
  • India
  • Australia & New Zealand
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Product, Application, End-User, and Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Product, Application, End-User, and Country/Sub-region)
  • GCC
  • South Africa
  • Rest of Middle East & Africa